Nature, Published online: 30 October 2019; doi:10.1038/s41586-019-1694-1
Treatment of KRASG12C-mutant cancer cells with the KRAS(G12C) inhibitor AMG 510 leads to durable response in mice, and anti-tumour activity in patients suggests that AMG 510 could be effective in patients for whom treatments are currently lacking.
from Nature - Issue - nature.com science feeds https://ift.tt/332xkvJ
Comments
Post a Comment